Cardiovascular effects of sildenafil in neonates and infants with congenital diaphragmatic hernia and pulmonary hypertension

Neonatology

Volumn 91, Issue 2, 2007, Pages 92-100

  Noori, Shahab ^a,c   Friedlich, Philippe ^a   Wong, Pierre ^b   Garingo, Arlene ^a   Seri, Istvan ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

Cardiac function; Echocardiogram; Nitric oxide

Indexed keywords

NITRIC OXIDE; SILDENAFIL;

ARTICLE; BIRTH WEIGHT; BLOOD PRESSURE; CARDIOVASCULAR EFFECT; CARDIOVASCULAR PARAMETERS; CLINICAL ARTICLE; CONGENITAL DIAPHRAGM HERNIA; CONTROLLED STUDY; ECHOCARDIOGRAPHY; GESTATIONAL AGE; HEART OUTPUT; HUMAN; LUNG VASCULAR RESISTANCE; LUNG VENTILATION; NEWBORN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RESPIRATORY SYSTEM; RETROSPECTIVE STUDY; SURVIVOR;

ADMINISTRATION, ORAL; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CARDIAC OUTPUT; ELECTROCARDIOGRAPHY; HERNIA, DIAPHRAGMATIC; HUMANS; HYPERTENSION, PULMONARY; INFANT; INFANT, NEWBORN; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; PULMONARY ARTERY; PURINES; RETROSPECTIVE STUDIES; SULFONES; VASCULAR RESISTANCE; VASODILATOR AGENTS;

EID: 33847014435     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000097125     Document Type: Article

References (29)

1. Bos AP, Tibboel D, Koot VC, et al: Persistent pulmonary hypertension in high-risk congenital diaphragmatic hernia patients: incidence and vasodilator therapy. J Pediatr Surg 1993;28:1463-1465.
2. Glick PL, Irish MS, Holm BA (eds): New insights into the pathophysiology of congenital diaphragmatic hernia. Clin Perinatol 1996;23:625-653.
3. The Neonatal Nitric Oxide Study Group (NINOS): Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. N Engl J Med 1997;336:597-604.
4. Clark RH, Kueser TJ, Walker MW, et al: Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. N Eng J Med 200;342:469-474.
5. The Neonatal Nitric Oxide Study Group (NINOS): Inhaled nitric oxide and hypoxic respiratory failure in infants with congenital diaphragmatic hernia. Pediatrics 1997;99:838-845.
6. Kinsella JP, Truog WE, Walsh WF, et al: Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn. J Pediatr 1997;131:55-62.
7. Wilkens H, Guth A, Konig J, et al: Effect of inhaled iloprost plus oral sildenafil in patients with primary pulmonary hypertension. Circulation 2001;104:1218-1222.
8. Travadi JN, Patole SK: Phosphodiestrase inhibitors for persistant pulmonary hypertension of the Newborn. Pediatr Pulmonol 2003;36:529-535.
9. Schulze-Neick I, Hartenstein P, Li J, et al: Intravenous sildenafil is a potent pulmonary vasodilator in children with congenital heart disease. Circulation 2003;108:II-167-II-173.
10. Atz AM, Wessel D: Sildenafil ameliorates effects of inhaled nitric oxide withdrawal. Anesthesiology 1999;91:307-310.
11. Atz AM, Lefler AK, Fairbrother DL, et al: Sildenafil augments the effect of inhaled nitric oxide for postoperative pulmonary hypertensive crises. J Thorac Cardiovasc Surg 2002;124:628-629.
12. Keller RL, Shannon EGH, Kitterman JA, et al: Treatment of rebound and chronic pulmonary hypertension with oral sildenafil in an infant with congenital diaphragmatic hernia. Pediatr Crit Care Med 2004;5:184-187.
13. Oliver J, Webb D: Sildenafil for 'blue babies': such unlicensed drug use might be justified as last resort. BMJ 2002;325:1174-1175.
14. Baquero H, Neira F, Venegas V, et al: Oral sildenafil for infants with persistent pulmonary hypertension of the newborn: a pilot randomized blinded study [abstract]. Pediatr Res 2006;117:1077-1083.
15. Skinner JR, Stuart AG, O'Sullivan J, et al: Right heart pressure determination by Doppler in infants with tricuspid regurgitation. Arch Dis Child 1993;69:216-220.
16. Dabestani A, Mahan G, Takenaka K, et al: Evaluation of pulmonary artery pressure and resistance by pulsed Doppler echocardiography. Am J Cardiol 1987;59:662-668.
17. Kitabatake A, Inoue M, Asao M, et al: Non-invasive evaluation of pulmonary hypertension by a pulsed Doppler technique. Circulation 1983;68:302-309.
18. Skinner J, Alverson D, Hunter S: Echocardiography for the Neonatologist. Edinburgh, Churchill Livingstone, 2000, pp 121-131.
19. Davis PJ, Firmin RK, Manktelow B, Goldman AP, Davis CF, Smith JH, Cassidy JV, Shekerdemian LS: Long-term outcome following extracorporeal membrane oxygenation for congenital diaphragmatic hernia: the UK experience. J Pediatr 2004;144:309-315.
20. Mickelakis E, Tymchak W, Lien D, et al: Oral sildenafil is effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension. Circulation 2002;105:2398-2403.
21. Evans NJ, Archer LN: Postnatal circulatory adaptation in healthy term and preterm neonates. Arch Dis Child 1990;65:24-26.
22. Shekerdemian LS, Ravn HB, Penny DJ: Intravenous sildenafil lowers pulmonary vascular resistance in a model of neonatal pulmonary hypertension. Am J Respir Crit Care Med 2002;165:1098-1102.
23. Cheitlin MD, Hutter AM, Brindis RG, et al: Use of sildenafil (Viagra) in patients with cardiovascular disease. ACC/AHA Expert consensus document. Circulation 1999;99:168-177.
24. Rabe KF, Dent TG, Schudt C, et al: Identification of PDE isozymes in human pulmonary artery and effect of selective PDE inhibitors. Am J Physiol 1994;266:536-543.
25. Behn D, Potter MJ: Sildenafil-mediated reduction in retinal function in heterozygous mice lacking the γ-subunit of phosphodiesterase. Invest Ophthalmol Vis Sci 2001;42:523-527.
26. Stocker C, Penny DJ, Brizard CP, Cochrane AD, Soto R, Shekerdemian LS: Intravenous sildenafil and inhaled nitric oxide: A randomised trial in infants after cardiac surgery. Intensive Care Med 2003;29:1996-2003.
27. Shekerdemian LS, Ravn HB, Penny DJ: Interaction between inhaled nitric oxide and intravenous sildenafil in a porcine model of meconium aspiration syndrome. Pediatr Res 2004;55:413-418.
28. Cohen MS, Rychik J, Bush DM, et al: Influence of congenital heart disease on survival in children with congenital diaphragmatic hernia. J Pediatr 2002;141:25-30.
29. Fauza DO, Wilson JM: Congenital diaphragmatic hernia and associated anomalies: their incidence, identification, and impact on prognosis. J Pediatr Surg 1994;29:1113-1117.